Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in CashFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Change in Account Payables (2021 - 2022)

Goldenwell Biotech filings provide 2 years of Change in Account Payables readings, the most recent being -$111488.0 for Q3 2022.

  • On a quarterly basis, Change in Account Payables changed N/A to -$111488.0 in Q3 2022 year-over-year; TTM through Mar 2024 was -$111488.0, a 0.0% change, with the full-year FY2022 number at -$111488.0, down 200.0% from a year prior.
  • Change in Account Payables hit -$111488.0 in Q3 2022 for Goldenwell Biotech, roughly flat from -$111488.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $8363.0 in Q4 2021 to a low of -$111488.0 in Q1 2022.